Table 3.
Case Group (n = 35,751) |
Control Group (n = 178,755) |
Crude HR (95% CI) |
Adjusted HR 1
(95% CI) |
p-Value | |||
---|---|---|---|---|---|---|---|
No. | % | No. | % | ||||
Male (n = 40,404) | |||||||
No osteoporosis | 6662 | 98.93 | 33,493 | 99.47 | 2.08 | 1.99 | <0.001 |
Osteoporosis | 72 | 1.07 | 177 | 0.53 | (1.58–2.73) | (1.50–2.65) | |
Female (n = 174,102) | |||||||
No osteoporosis | 28,278 | 97.45 | 142,896 | 98.49 | 1.71 | 1.80 | <0.001 |
Osteoporosis | 739 | 2.55 | 2189 | 1.51 | (1.57–1.86) | (1.65–1.96) |
1 Adjusted for age, gender, occupation, urbanization, insurable wage, and co-morbidities.